The 33 references without contexts in paper K. Mukhin Yu., O. Pylaeva A., К. Мухин Ю., О. Пылаева А. (2017) “Юношеская миоклоническая эпилепсия: акцент на применение топирамата (обзор литературы и собственные данные) // JUVENILE MYOCLONIC EPILEPSY: FOCUS ON THE USE OF TOPIRAMATE (LITERATURE REVIEW AND OWN DATA)” / spz:neicon:rjdn:y:2017:i:2:p:8-20

1
Petrukhin A.S. Side effects of antiepileptic drugs. Moscow: Granat, 2016. 236 p. (In Russ.)]. 8. Холин А.А., Федонюк И. Д., Колпак- чи Л.М. и др. Аггравация эпилепсии при терапии леветираце
(check this in PDF content)
2
DOI: 10.1212/01.wnl.0000313148.34629.1d. 11. Ben-Menachem E. Levetiracetam: treatment in epilepsy. Expert Opin Pharmacother 2003;4(11):2079–88.
(check this in PDF content)
3
DOI: 10.1517/14656566.4.11.2079. 12. Biraben A., Allain H., Scarabin J.M. et al. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurolo
(check this in PDF content)
4
PMID: 11113246. 13. Birnbaum D., Koubeissi M. Unmasking of myoclonus by lacosamide in generalized epilepsy. Epilepsy Behav Case Rep 2016;7:28–30.
(check this in PDF content)
5
DOI: 10.1016/j.ebcr.2016.09.006. 14. Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009;73
(check this in PDF content)
6
DOI: 10.1212/WNL.0b013e3181b9c86f. 15. Chowdhury A., Brodie M.J. Pharmacological outcomes in juvenile myoclonic epilepsy: support for sodium valproate.
(check this in PDF content)
7
Epilepsy Res 2016;119(1):62–6.
(check this in PDF content)
8
DOI: 10.1016/j.eplepsyres.2015.11.012. 16. Crespel A., Gelisse P., Reed R.C. et al. Management of juvenile myoclonic epilepsy. Epilepsy Behav 2013;28(1):S81–6.
(check this in PDF content)
9
DOI: 10.1016/j.yebeh.2013.01.001. 17. Crespel A., Genton P., Berramdane M. et al. Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic
(check this in PDF content)
10
DOI: 10.1212/01.wnl.0000174517.21383.36. 18. Crespel A., Velizarova R., Genton P. et al. Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate. Therapie 200
(check this in PDF content)
11
DOI: 10.2515/therapie/2009033. 19. Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classif
(check this in PDF content)
12
PMID: 11422340. 20. Epilepsies: diagnosis and management: clinical guideline. URL: https://www.nice. org.uk/guidance (last access date: 10.05.2017
(check this in PDF content)
13
PMID: 19300616. 22. Gelisse P., Genton P., Kuate C. et al. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 2004;45(10):12
(check this in PDF content)
14
DOI: 10.1111/j.0013-9580.2004.19704.x. 23. Genton P., Gelisse P., Thomas P. Juvenile myoclonic epilepsy today: current definition and limits. In: Juvenile myoclonic epilepsy: the Janz s
(check this in PDF content)
15
DOI: 10.1111/epi.13702. 26. Glauser T., Ben-Menachem E., Bourgeois B. et al. The ILAE Subcommission on
(check this in PDF content)
16
AED Guidelines Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia
(check this in PDF content)
17
DOI: 10.1111/epi.12074. 27. Gomez-Ibañez A., McLachlan R.S., Mirsattari S.M. et al. Prognostic factors in patients with refractory idiopathic generalized epilepsy. Epilepsy
(check this in PDF content)
18
DOI: 10.1016/j.eplepsyres.2017.01.011. 28. Grunewald R.A. Juvenile myoclonic epilepsy. In: Atlas of Epilepsies. Ed. by C.P. Panayiotopoulos. London: Springer, 2010. Pp.
(check this in PDF content)
19
PMID: 3936330. 31. Janz D. Juvenile myoclonic epilepsy. In: Comprehensive epileptology. Eds. by M.
(check this in PDF content)
20
Dam, L. Gram. New York: Raven Press, 1991. Pp. 171–185. 32. Janz D., Christian W. Impulsiv – petit mal. J Neurol 1957;176:346–86. 33. Japaridze G., Kasradze
(check this in PDF content)
21
DOI: 10.1016/j.clinph.2015.11.048. 34. Johannesen K., Marini C., Pfeffer S. et al. Phenotypic spectrum of GABRA1: from generalized epilepsies to severe epileptic
(check this in PDF content)
22
DOI: 10.1212/WNL.0000000000003087. 35. Kwan P., Sills G.J., Brodie M.J. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther 2001;90(1):21–3
(check this in PDF content)
23
DOI: 10.1016/j.yebeh.2007.03.003. 37. Liu J., Wang L.N., Wang Y.P. Topiramate monotherapy for juvenile myoclonic epilepsy. Cochrane Database Syst Rev 2015;(12):CD010
(check this in PDF content)
24
DOI: 10.1002/14651858.CD010008.pub2. 38. Loddenkemper T., Berg A.T. Terminology for seizures and epilepsies. In: Wyllie’s treatment of epilepsy. Principles and practice. 6t
(check this in PDF content)
25
New York: Springer, 2010. Pp. 174–179. 41. Panayiotopoulos C.P. Idiopathic generalized epilepsies. New York: Springer, 2012. Pp. 41–44. 42. Panayiotopoulos C.P., Obeid T., Tahan
(check this in PDF content)
26
DOI: 10.1016/j.jocn.2012.10.020. 45. Perucca E. The spectrum of the new antiepileptic drugs. Acta Neurol Belg 1999;99(4):231–8. PMID: 10674140. 46. Privitera M.
(check this in PDF content)
27
Acta Neurol Scand 2003;107(3):165–75.
(check this in PDF content)
28
PMID: 12614309. 47. Shorvon S. We live in the age of the clinical guideline. Epilepsia 2006;47(7):1091–3.
(check this in PDF content)
29
DOI: 10.1111/j.1528-1167.2006.00584.x. 48. So G.M., Thiele E.A., Sanger T. et al. Electroencephalogram and clinical focalities in juvenile myoclonic epilepsy. J. Child Neurol 1998;
(check this in PDF content)
30
DOI: 10.1177/088307389801301103. 49. Thomas P., Genton P., Gelisse P. et al. Juvenile myoclonic epilepsy. In: Epileptic syndromes in infancy,
(check this in PDF content)
31
John Libbey Eurotext, 2012. Pp. 305–328. 50. Wolf P. Juvenile myoclonic epilepsy. In: Epileptic syndromes in infancy, childhood and adolescence. Paris:
(check this in PDF content)
32
John Libbey Eurotext, 1992. Pp. 316–327. 51. Yacubian E.M. Juvenile myoclonic epilepsy: challenges on its 60th anniversary. Seizure 2017;44:48–52.
(check this in PDF content)
33
DOI: 10.1016/j.seizure.2016.09.005. Поступила: 21.04.2017. Рецензирование: 12.05.2017. Принята в печать: 27.05.2017 Received: 21.04.2017. Reviewing: 12.05.2017.
(check this in PDF content)